cd8+

  1. forestglip

    Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, 2011, Brenu et al

    Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Ekua W Brenu, Mieke L van Driel, Don R Staines, Kevin J Ashton, Sandra B Ramos, James Keane, Nancy G Klimas & Sonya M Marshall-Gradisnik Published: 28 May 2011 Background Chronic Fatigue...
  2. forestglip

    HLA-A*03 may confer protection against long COVID through an enhanced immune response, 2025, Pons-Fuster et al

    HLA-A*03 may confer protection against long COVID through an enhanced immune response Eduardo Pons-Fuster, Rodrigo Martinez-Rodriguez, Lourdes Gimeno-Arias, M.J. Alcaraz, Marta Moreno, Jose M. Gómez, Ana Pelaez, Elisa García, Cristina Tomás, Angeles Muñoz, María V. Martínez-Sánchez, Inmaculada...
  3. forestglip

    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination, 2025, Karl et al

    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination Vivien Karl, Maike Hofmann, Robert Thimme [Line breaks added] Abstract The COVID-19 pandemic has greatly enhanced our understanding of CD8+ T cell immunity and their role in natural infection and vaccine-induced...
  4. E

    Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Iu, Hanson et al

    Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome Significance Myalgic encephalomyelitis/chronic fatigue syndrome (ME) is a serious disabling chronic illness that lacks FDA-approved therapies. Comprehensive...
  5. J

    Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection, Matthews et al, 2024

    n=31 Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection Abstract This study investigates the humoral and cellular immune responses and health-related quality of life measures in individuals with mild to moderate long COVID (LC)...
Back
Top